By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Telesta Therapeutics (Formerly known as Bioniche Life Sciences) 

275 Labrosse Avenue

Pointe-Claire  Quebec  H9R 1A3  Canada
Phone: 514-697-6636 Fax: 613-966-9485


Company News
After FDA Type A Meeting, Telesta (TSX:TST) Eyes Major Restructuring and a Partner to Continue Phase III Trial 4/18/2016 6:00:08 AM
Telesta (TSX:TST) Corporate Update - Type A Meeting With The FDA Scheduled 4/13/2016 7:02:18 AM
Telesta (TSX:TST) Requests Meeting With FDA Over Bladder Cancer Drug, Slashes Jobs by 15% 3/9/2016 5:50:25 AM
Telesta (TSX:TST) Publishes Its Q2, 2016 Financial Statements And Provides Corporate Updates 2/12/2016 6:07:39 AM
Telesta (TSX:TST) Receives Complete Response Letter From FDA 2/2/2016 2:21:41 PM
Telesta (TSX:TST) Corporate Update 12/14/2015 6:32:05 AM
FDA Panel Rejects Telesta (TSX:TST)'s Bladder Cancer Drug MCNA 11/19/2015 6:11:36 AM
Telesta (TSX:TST) Announces Results Of Annual General Meeting Of Shareholders 11/16/2015 10:21:18 AM
Telesta (TSX:TST) Publishes Its Q1, 2016 Financial Statements And Provides Corporate Updates 11/12/2015 10:22:50 AM
Telesta (TSX:TST), Ipsen (IPN.PA) Strike $137 Million+ Bladder Cancer Pact 10/28/2015 6:06:19 AM